Lyophilization Stoppers

Lyophilization Stoppers
Product Description

Aptar Pharma's Lyophilization Stoppers ensure stability and excellent performance during the freeze-drying process.

Aptar Pharma

  • FR
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Packaging supplier/manufacturer
Primary activities
Contract Research Organisation
Medical Devices
Packaging & drug delivery

Aptar Pharma

  • FR
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Packaging supplier/manufacturer
Primary activities
Contract Research Organisation
Medical Devices
Packaging & drug delivery

More Products from Aptar Pharma (44)

  • Activ-Vial™ Portfolio

    Product Activ-Vial™ Portfolio

    Aptar CSP's Activ-Vial™ portfolio offers 3-Phase Activ-Polymer™ flip-top vials and bottles in various sizes, providing superior protection for product stability and extended shelf life.
  • Activ-Film™ Material

    Product Activ-Film™ Material

    Aptar CSP Technologies' Activ-Film™ material optimizes product stability through imperceptible enhancements for consumers and increased efficiency for manufacturers.
  • Landmark®

    Product Landmark®

    Aptar Pharma's Landmark® dose counting device is FDA compliant and compatible with all pMDIs, including nasal actuators. 
  • APF Advanced Preservative Free

    Product APF Advanced Preservative Free

    The Advanced Preservative Free (APF) and APF + pumps are innovative, metal-free dispensing systems for nasal and topical use, providing robust microbiological protection for sensitive formulations. The highly recyclable, all-plastic APF Futurity™ system marks a breakthrough in multidose nasal spray tec...
  • PureHale® Technology Platform

    Product PureHale® Technology Platform

    Aptar Pharma's PureHale® Technology Platform is the first portable, pre-filled nebulizer –like device that, when used with saline or natural ingredient formulations, alleviates upper respiratory symptoms like coughs, colds, allergies, and dry nose and throat.
  • Classic Line and VP6 Technology Platforms

    Product Classic Line and VP6 Technology Platforms

    Aptar Pharma offers versatile and reliable Classic Line and VP6 spray pump technologies for multi-dose dispensing. Our modular solutions cater to diverse global markets, serving a wide range of products, from regulated prescriptions to over-the-counter and consumer health brands.
  • Needle Shields

    Product Needle Shields

    Aptar Pharma leads in elastomeric Rigid Needle Shields (RNS) for PFS and Auto-injector developments. Trusted by top manufacturers, we offer safe, high-quality solutions for injectables.
  • Tip Caps

    Product Tip Caps

    Aptar Pharma is a global leader in elastomeric Tip Caps, offering high-quality Pre-Filled Syringe components with unique rubber formulation for effective drug protection and safety in injectable developments. 
  • Small Volume Parenteral Stoppers

    Product Small Volume Parenteral Stoppers

    Aptar Pharma's Serum Stoppers offer optimal protection and drug delivery for blowback and non-blowback vials. 
  • Large Volume Parenteral Stoppers

    Product Large Volume Parenteral Stoppers

    Aptar Pharma's Infusion Stoppers provide optimal protection and drug delivery for infusion bottles, meeting multi-piercing needs and streamlining manufacturing processes.
  • Plungers

    Product Plungers

    Aptar Pharma is a global leader in elastomeric Plungers for Pre-Filled Syringes, providing safe and high-quality solutions for injectable developments.
  • AdhereIT®

    Product AdhereIT®

    AdhereIT® is a connected medical device that enhances patient adherence for self-injecting medication. It supports training and autoinjector devices, alleviating anxieties and promoting proper usage. Through multisensory feedback and app features, AdhereIT® enables patients to start treatment sooner an...

Aptar Pharma resources (3)

  • Video Innovations in Inhalation

    Aptar Pharma's presentation entitled "Innovations in Inhalation" explores the current extensive portfolio of high-quality OINDP (Orally Inhaled and Nasal Drug Products) delivery devices. The presentation also highlights Aptar Pharma's comprehensive services which support respiratory drug development, including device selection, formulation development, analytical methods, and regulatory support. A key focus of the talk is the introduction of Orbital, an innovative high payload DPI system designed to enhance drug delivery efficiency and patient compliance. This discussion aims to showcase Aptar Pharma's latest advancements in inhalation technology, emphasizing their commitment to improving patient care through innovative drug delivery systems.
  • Video The Pharma Challenge With Scope 3 Emissions – Collaborative Ways to Reduce Our CO2 Footprint

    Big Pharma reports that up to over 90% of their CO2 emissions are scope 3. This is not only a huge burden but also the most difficult part to influence for pharmaceutical industry. However, there are ways to manage and collaborate in the industry. Christophe Marie from Aptar Group will highlight how Aptar implemented specific targets with partners and suppliers to tackle the scope 3 challenge, coming from a consumer market perspective, extrapolating into the pharmaceutical business. Also, when talking about products we are increasingly facing requests to minimize our CO2 footprint in Pharma. A great example for collaborative approaches helping to de-risk and accelerate our clients’ low GWP pressurized Metered Dose Inhaler (pMDI) programs will be illustrated by Chris Baron, based on the transition of the current pMDIs to alternative low GWP propellant technologies. Join Christophe Marie and Chris Baron at CPHI to learn how Aptar Pharma supports more sustainable product